Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U. Peled, João B. Xavier, Ann E. Slingerland et al.|New England Journal of Medicine|2020Cited by 739
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell TransplantationRainer Storb, Brenda M. Sandmaier, Boglarka Gyurkocza et al.|Journal of Clinical Oncology|2013Cited by 212
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignanciesRobert Stuver, Santosha A. Vardhana, Gunjan L. Shah et al.|Cancer Cell|2022Cited by 88
Phase I/II multisite trial of optimally dosed clofarabine and low‐dose TBI for hematopoietic cell transplantation in acute myeloid leukemiaElizabeth F. Krakow, Brenda M. Sandmaier, Boglarka Gyurkocza et al.|American Journal of Hematology|2019Cited by 7